Currently, a randomized, controlled clinical trial is underway, specifically studying the effectiveness of MERIT for persons with Schizophrenia. More information here.
Results of multiple trials are needed to robustly confirm the effectiveness of the MERIT intervention. Future research is needed to explore these applicability and generalization issues systematically across different settings.
For example, we need to learn more about how the various dimensions of metacognition co-vary across clinical improvement; how they are associated with psychosis and residual symptoms; and what refinements we can make in the MERIT protocol to accelerate and consolidate gains in metacognitive functioning.
Multi-site and international collaborators are under recruitment by MERIT Institute, P.C., for ongoing validation study of MERIT therapy. Our main focus is on schizophrenia-spectrum disorders, but also other psychotic disorders.
Interested clinical scientists, practitioners, and clients are invited to get in touch with us regarding training, research, and clinical services offered by MERIT Institute, P.C. and its affiliated network of MERIT-trained practitioners.